Literature DB >> 4106491

Macrophage-melanoma cell heterokaryons. 3. The activation of macrophage DNA synthesis. Studies with inhibitors of protein synthesis and with synchronized melanoma cells.

S Gordon, Z Cohn.   

Abstract

Dormant macrophage nuclei initiate DNA synthesis 2-3 hr after fusion of macrophages with exponentially growing melanoma cells. Cycloheximide treatment (1-5 microg/ml) of heterokaryons during the preceding lag period inhibits the initiation of macrophage DNA synthesis, in a reversible fashion. Each type of cell was also treated with streptovitacin A, an irreversible inhibitor of protein synthesis. Pretreatment of the melanoma cells (0.5-2 microg/ml), 1 hr before fusion, inhibited the induction of macrophage DNA synthesis in heterokaryons, whereas pretreatment of macrophages (1-20 microg/ml) had no effect. Melanoma cell pretreatment reduced the incorporation of leucine-(3)H into the cytoplasm and nuclei of heterokaryons, whereas macrophage pretreatment had no effect. These experiments suggested that melanoma proteins played an important role in the initiation of macrophage DNA synthesis. The relationship between the melanoma cell cycle and macrophage DNA synthesis was studied with synchronous melanoma cells. If the melanoma cells were in S phase at the time of fusion, macrophage DNA synthesis occurred 2 hr later. However, the fusion of melanoma cells in G(1) delayed macrophage DNA synthesis until the melanoma nuclei had entered S. Experiments with actinomycin and cycloheximide showed that RNA and protein, essential to achieve DNA synthesis in the macrophage nucleus, were made during late G(1) as well as S. Melanoma cells and macrophages differ in their radiolabeled acid-soluble products after incubation in thymidine-(3)H. Thymidine taken up by the macrophage remained unphosphorylated, whereas it was recovered mainly as thymidine triphosphate from melanoma cells. These findings, as well as those reported previously, suggest that the melanoma cell provides the RNA, protein, and precursors which initiate macrophage DNA synthesis. In the absence of a requirement for new macrophage RNA and protein synthesis, other changes must be responsible for the 2 hr delay in DNA synthesis. These may involve physical changes in DNA, associated with swelling, as well as the transport of melanoma products into the macrophage nucleus.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4106491      PMCID: PMC2138993          DOI: 10.1084/jem.134.4.935

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Structural basis for inhibition of protein synthesis by emetine and cycloheximide based on an analogy between ipecac alkaloids and glutarimide antibiotics.

Authors:  A P Grollman
Journal:  Proc Natl Acad Sci U S A       Date:  1966-12       Impact factor: 11.205

2.  Deoxyribonucleotide pools and deoxyribonucleic acid synthesis in cultured mouse embryo cells.

Authors:  B A Nordenskjöld; L Skoog; N C Brown; P Reichard
Journal:  J Biol Chem       Date:  1970-10-25       Impact factor: 5.157

Review 3.  The cytoplasmic control of nuclear activity in animal development.

Authors:  J B Gurdon; H R Woodland
Journal:  Biol Rev Camb Philos Soc       Date:  1968-05

4.  Biochemical events in the animal cell cycle.

Authors:  G C Mueller
Journal:  Fed Proc       Date:  1969 Nov-Dec

5.  Structure-activity studies with cycloheximide and congeners.

Authors:  H L Ennis
Journal:  Biochem Pharmacol       Date:  1968-07       Impact factor: 5.858

6.  Mammalian cell fusion: studies on the regulation of DNA synthesis and mitosis.

Authors:  P N Rao; R T Johnson
Journal:  Nature       Date:  1970-01-10       Impact factor: 49.962

7.  The reactivation of the red cell nucleus.

Authors:  H Harris
Journal:  J Cell Sci       Date:  1967-03       Impact factor: 5.285

8.  Macrophage-melanocyte heterokaryons. I. Preparation and properties.

Authors:  S Gordon; Z Cohn
Journal:  J Exp Med       Date:  1970-05-01       Impact factor: 14.307

9.  Changes in the cytochemical properties of erythrocyte nuclei reactivated by cell fusion.

Authors:  L Bolund; N R Ringertz; H Harris
Journal:  J Cell Sci       Date:  1969-01       Impact factor: 5.285

10.  Macrophage-melanocyte heterokaryons. II. The activation of macrophage DNA synthesis. Studies with inhibitors of RNA synthesis.

Authors:  S Gordon; Z Cohn
Journal:  J Exp Med       Date:  1971-02-01       Impact factor: 14.307

View more
  10 in total

1.  Heterokaryons in the analysis of genes and gene regulation.

Authors:  J Zeuthen
Journal:  Humangenetik       Date:  1975

2.  Late S phase cells (Chinese hamster ovary) induce early S phase DNA labeling patterns in G1 phase nuclei.

Authors:  R M Yanishevsky; D M Prescott
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

Review 3.  Use of somatic cell hybrids for analysis of the differentiated state.

Authors:  F M Davis; E A Adelberg
Journal:  Bacteriol Rev       Date:  1973-06

4.  Macrophage polykaryon formation in vitro by peritoneal cells from mice given injections of sodium periodate.

Authors:  J B Weinberg
Journal:  Am J Pathol       Date:  1983-02       Impact factor: 4.307

5.  Tumor-host cell hybrids in radiochimeras.

Authors:  F Wiener; E M Fenyö; G Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1974-01       Impact factor: 11.205

6.  Cell cycle studies of mononucleate and cytochalasin-B--nduced binucleate fibroblasts.

Authors:  R E Fournier; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

Review 7.  Cell fusion and some subcellular properties of heterokaryons and hybrids.

Authors:  S Gordon
Journal:  J Cell Biol       Date:  1975-11       Impact factor: 10.539

8.  Macrophage-melanoma cell heterokaryons. IV. Unmasking the macrophage-specific membrane receptor.

Authors:  S Gordon; Z Cohn
Journal:  J Exp Med       Date:  1971-10-01       Impact factor: 14.307

9.  Fibronectin expression is determined by the genotype of the transformed parental cells in heterokaryons between normal and transformed fibroblasts.

Authors:  P Laurila; J Wartiovaara; S Stenman
Journal:  J Cell Biol       Date:  1979-01       Impact factor: 10.539

10.  Zanvil Alexander Cohn 1926-1993.

Authors:  R M Steinman; C L Moberg
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.